ARTV

ARTIVA BIOTHERAPEUTICS INC

Data as of 2026 Q2 (06-30) · 13F snapshot

Summary

ARTIVA BIOTHERAPEUTICS INC (ARTV) is held as common stock by 3 tracked hedge-fund managers, with a combined reported value of ~$32.64M; the largest are Andreas Halvorsen, Ken Griffin, Renaissance Technologies. This quarter: 1 new, 2 added, 1 closed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.

Attention · LowThis quarter · Heating up

Common-stock holders3

Congress trades0

Price$7.03vs quarter-end-27.53%

Sectors0

This quarter's moves

New1

Added2

Trimmed / sold1

Top holder

Andreas Halvorsen

Common-stock positions

PUT and CALL disclosures are excluded from these holder counts and values.

Investor	Period	Value	Shares	% of portfolio	Action

Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.